SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows | Latest News RSS feed

SGLT-2 Inhibitors Cut Risk Of Death In Diabetics, Data Shows - Latest News


SGLT-2 inhibitors cut risk of death in diabetics, data shows

AstraZeneca has unveiled findings of a new analysis of data from the CVD-REAL study, showing a significant cut in the risk of all-cause death (ACD) in patients with type II diabetes taking SGLT-2 inhi... read more

Certain SGLT2 inhibitors, GLP-1 RAs for T2DM also cut CV risk

The authors note that specific medications in these classes can reduce rates of acute myocardial infarction, stroke, and CV death; SGLT2 inhibitors ... data show evidence of benefit in reducing CV ... read more

Real-world study shows type 2 diabetics treated with SGLT-2 inhibitors experienced less risk of hospitalization for heart failure and death

The data showed that treatment with SGLT-2 inhibitors ... and death from any cause by 51% (hazard ratio = 0.49; p<0.001). For the composite endpoint of hospitalization for heart failure and all-cause ... read more

Looking for another news?


Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and ... according to data released on Sunday from a so-called real world study sponsored by AstraZenec... read more


Astrazeneca global study reveals diabetes medication significantly cuts death rates

Astrazeneca has hailed the success of its new Type 2 diabetes drugs, after a study of more than 300,000 people revealed it significantly cut the risk of death or heart failure ... whether the medicati... read more

Newer type 2 diabetes drugs show heart protective quality in study

WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death ... according to data released on Sunday from a so-called real world study sponsored by Astr... read more

Newer type 2 diabetes drugs show heart protective quality: study

The drugs, known as SGLT-2 inhibitors ... diabetes. (Representational Image) A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared w... read more

Trial shows heart benefits of Novo’s diabetes drug Victoza

Hotly-anticipated data on Novo Nordisk's diabetes therapy Victoza show that the drug significantly cut the risk ... of death worldwide in this patient population." The drug now joins the ranks of Eli ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us